Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (4) , 547-553
- https://doi.org/10.1097/00004872-199917040-00013
Abstract
Studies using cell cultures and animal models have indicated an important role for angiotensin II in atherosclerosis. In humans, at least two major enzymes are involved in the conversion of angiotensin I to angiotensin II: so-called angiotensin-converting enzyme (ACE) and chymase. Enhanced activation of chymase in atherosclerotic tissue homogenates has been reported in animal models, but its contribution to the generation of angiotensin II has not been studied. To clarify the localization of chymase and its pathophysiologic role in the formation of angiotensin II, using human coronary arteries. Twenty-four coronary artery segments obtained from 14 autopsied patients were characterized histologically into the following categories: normal coronary arteries with diffuse intimal thickening, hypercellular lesions, atheromatous plaques and fibrosclerotic plaques. We compared the cellular localization of chymase, ACE and angiotensin II expression using immunocytochemical techniques. Chymase was expressed only in the cytosole of mast cells in all segments. On the basis of the histologic study, the number of chymase-positive cells in the intima of atheromatous plaques was significantly higher than that in normal coronary arteries with diffuse intimal thickening. The expression of angiotensin II in the intima was enhanced in hypercellular lesions and atheromatous plaques. Localization of angiotensin II in the intima was associated with that of ACE. Immunodouble staining did not show colocalization of angiotensin II and chymase. These results suggest an important role for the production of angiotensin II by ACE in the progression of atherosclerosis in human coronary arteries. Enhanced expression of chymase appears not to be involved in angiotensin II production in the intima.Keywords
This publication has 26 references indexed in Scilit:
- Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.Circulation, 1997
- Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humansJournal Of Hypertension, 1997
- Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of AtherosclerosisCirculation, 1995
- Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation.Circulation, 1994
- Angiotensin converting enzyme inhibition and coronary artery diseaseJournal Of Hypertension, 1994
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- EFFECT OF PERINDOPRIL ON THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE CHOLESTEROL-FED RABBITClinical and Experimental Pharmacology and Physiology, 1992
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.Hypertension, 1992